Reflectance and/or transmissive pulse oximeter
According to various embodiments, a medical sensor assembly may be configured to switch between transmission and reflectance mode. Such sensors may include multiple optical sensing components that may be activated or silent, depending on the mode in use. A practitioner may switch between modes based on the particular situation of the patient or based on the signal quality.
1. A sensor comprising:
a sensor body adapted to be applied to a patient's tissue;
a first emitter and a second emitter disposed on the sensor body;
a detector disposed on the sensor body, wherein the first emitter and the detector are capable of operating in transmission mode and the second emitter and the detector are capable of operating in reflectance mode;
a switch disposed on the sensor body and coupled to the first emitter and the second emitter; and
a processor-based controller disposed on the sensor body and configured to receive an input from the detector, wherein the controller is configured to control the switch to alternate between activation of the first emitter and the second emitter based on the input.
2. The sensor, as set forth in claim 1 , wherein the sensor comprises at least one of a pulse oximetry sensor or a sensor for measuring a water fraction.
3. The sensor, as set forth in claim 1 , wherein first emitter or the second emitter comprises at least one light emitting diode and wherein the detector comprises at least one photodetector.
4. The sensor, as set forth in claim 1 , wherein the first emitter and the detector are spaced apart about 20 mm to about 25 mm or wherein the second emitter and the detector are spaced apart about 8 mm to about 14 mm.
5. The sensor, as set forth in claim 1 , wherein the controller is configured to receive a signal from the detector and detect a signal artifact in the signal.
6. The sensor, as set forth in claim 5 , wherein the controller is configured to switch from transmission mode or reflectance mode if the controller detects the signal artifact.
7. The sensor, as set forth in claim 5 , wherein the controller is configured to arbitrate between transmission mode and reflectance mode to mitigate the signal artifact in the signal.
8. The sensor, as set forth in claim 5 , wherein the controller is configured to switch from reflectance mode to transmission mode in the presence of a signal artifact comprising a η-artifact.
9. The sensor, as set forth in claim 5 , wherein the controller is configured to switch between reflectance mode and transmission mode during the time an α-artifact or a ΔP tiss -artifact is detected.
10. The sensor, as set forth in claim 1 , comprising an encoder, wherein the encoder comprises stored data related to the sensor.
11. A system comprising:
a sensor comprising:
a sensor body adapted to be applied to a patient's tissue;
a first emitter and a second emitter disposed on the sensor body;
a detector disposed on the sensor body, wherein the first emitter and the detector are capable of operating in transmission mode and the second emitter and the detector are capable of operating in reflectance mode, and wherein the sensor is capable of alternating between transmission mode and reflectance mode; and
a monitor comprising a processor configured to:
detect a signal artifact in a signal from the sensor;
determine a characteristic of the signal artifact; and
control the activation of the first emitter and the second emitter based on the characteristic of the signal artifact.
12. The system, as set forth in 11 , wherein the sensor comprises at least one of a pulse oximetry sensor or a sensor for measuring water fraction.
13. The system, as set forth in claim 11 , wherein the first emitter and the detector are spaced apart about 20 mm to about 25 mm or wherein the second emitter and the detector are spaced apart about 8 mm to about 14 mm.
14. The system, as set forth in claim 11 , wherein the characteristic of the signal artifact comprises determining if the signal artifact comprises one or more of an η-artifact, α-artifact, ΔP tiss -artifact, heterogeneity artifact, or boundary condition artifact.
15. The system, as set forth in claim 14 , wherein the monitor is configured to determine a type of patient motion based on the presence of one or more of the η-artifact, α-artifact, ΔP tiss -artifact, heterogeneity artifact, or boundary condition artifact.
16. The system, as set forth in claim 11 , wherein the sensor comprises a switch disposed on the sensor body and coupled between the first emitter and the second emitter.